- Filed
- May 20, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 17, 2024 | 9.02M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 2.81M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 272.41K sh |
| Capex | Q1 2024 · Mar 31, 2024 | $3.74K |
| Capex | Q1 2024 · Mar 31, 2023 | $15.19K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$2.25M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$2.17M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $166.2K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $452.45K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $2.51M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $13.79M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $11.42M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $3.34M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $4.42M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $4.31M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $5.82M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $2.01M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $3.9M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $18.9M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $18.13M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$1.47 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$8.55 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$1.47 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$8.55 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $1.54M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $1.88M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$3.96M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$2.14M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$1.76M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$1.77M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $262.34K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $540.14K |